Ingevity Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 18 out of 67 in the Chemicals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 79.25.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Media Coverage
The current financial score of Ingevity Corp is 6.80, ranking 43 out of 67 in the Chemicals industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 255.10M, representing a year-over-year decrease of 14.63%, while its net profit experienced a year-over-year decrease of 609.64%.
The current valuation score of Ingevity Corp is 7.68, ranking 35 out of 67 in the Chemicals industry. Its current P/E ratio is -15.47, which is -205.87% below the recent high of 16.37 and -2039.04% above the recent low of -330.83.

The current earnings forecast score of Ingevity Corp is 8.00, ranking 7 out of 67 in the Chemicals industry. The average price target is 67.50, with a high of 77.00 and a low of 55.00.


Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Ingevity Corp is 8.58, ranking 33 out of 67 in the Chemicals industry. Currently, the stock price is trading between the resistance level at 74.72 and the support level at 65.44, making it suitable for range-bound swing trading.

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Ingevity Corp is 10.00, ranking 1 out of 67 in the Chemicals industry. The latest institutional shareholding proportion is 106.72%, representing a quarter-over-quarter increase of 4.27%. The largest institutional shareholder is The Vanguard, holding a total of 4.02M shares, representing 11.38% of shares outstanding, with 1.81% increase in holdings.

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Chemicals domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Ingevity Corp is 6.25, ranking 32 out of 67 in the Chemicals industry. The company's beta value is 1.28. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.